Taiwan FDA registration 5ffd8356937121f4d7f0759105097134
RAMP NT-proBNP Assay
TW: “倫普”N端前B型利鈉肽檢驗試劑組
Taiwan·Risk Class 2·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Aug 26, 2015 – Aug 26, 2025ExpiredRegistration details
- Analysis ID
- 5ffd8356937121f4d7f0759105097134
- License Form
- Ministry of Health Medical Device Import No. 027561
- Customs Code
- DHA05602756101
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- With RAMP Reader System or RAMP 200 System, immunochromography, the concentration of NT-proBNP in EDTA whole blood was quantitatively detected.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1117 Type B sodium urine peptide test system
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 26, 2015
- Expiry Date
- Aug 26, 2025
About this record
Access comprehensive regulatory information for RAMP NT-proBNP Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5ffd8356937121f4d7f0759105097134 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices